The FDA approved Spravato for those battling depression and has seen little to no improvement from two types of ...

Exploring use of Altamira's RNA nanoparticles in conjunction with radiopharmaceutical cancer treatment Project collaboration partner will have option ...

Project collaboration partner will have option to negotiate licensing and supply agreement ...

The FDA approved Johnson & Johnson’s Spravato nasal spray as a stand-alone treatment for patients suffering from severe ...

You should change the pads every 48 hours, and note that they do not work on moles, birthmarks, warts with hair growing from ...

Indonesian rescuers retrieved two more bodies after they resumed their search Wednesday for people missing after floods and landslides on Indonesia’s main island of Java, ...

President Donald Trump has signed an executive order promising to eliminate what he incorrectly labels “the electric vehicle ...

The flu, caused by influenza viruses that are always changing, leads to fever, chills, cough, sore throat, runny nose, body ...

J&J on Tuesday said the green light makes Spravato the first and only monotherapy for adults with major depressive disorder who have had an inadequate response to at least two oral antidepressants.

Pain Management Market Advancements in non-opioid therapies, AI-integrated solutions, and regenerative <a target=_blank href= ...

As Los Angeles contends with the devastating effects of wildfires, medical experts provide tips to protect your lungs, skin ...

Medical experts believe nalmefene shouldn’t replace naloxone because of an increased risk for severe withdrawal symptoms ...